ENDRA Life Sciences (NDRA) Revenue (2016 - 2018)

ENDRA Life Sciences has disclosed Revenue across 3 years of filings, most recently posting $6174.0 for Q1 2018.

• In Q1 2018, Revenue changed N/A year-over-year to $6174.0; the TTM figure through Dec 2018 stood at $6174.0 (down 98.24% YoY), while the FY2018 annual figure was $6174.0, down 98.24% from the prior year.
• Revenue fell to $6174.0 in Q1 2018, from $6850.0 in the prior quarter.
• Over the last five years, Revenue for NDRA reached as high as $515582.0 in Q4 2016 and fell as low as $6174.0 in Q1 2018.
• The 3-year median for Revenue is $57772.0 (2017), against an average of $174675.6.
• The widest YoY moves for Revenue: up 98.67% in 2017, down 98.67% in 2017.
• A 3-year view of Revenue shows it stood at $515582.0 in 2016, then tumbled by 98.67% to $6850.0 in 2017, then decreased by 9.87% to $6174.0 in 2018.
• According to Business Quant data, Revenue over the past three periods registered $6174.0, $6850.0, and $287000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.